メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
東北大学 ホーム
ヘルプ＆FAQ
English
日本語
ホーム
プロファイル
研究部門
研究成果
プレス/メディア
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
Tarasawa Kunio
准教授
医学系研究科・公衆衛生学専攻
h-index
245
被引用数
8
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2020
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(44)
プレス/メディア
(5)
類似のプロファイル
(6)
フィンガープリント
Kunio Tarasawaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Observational Study
100%
Propensity Score Matching
94%
Odds Ratio
85%
Ulcerative Colitis
72%
Elderly Patient
67%
Hip Fracture
66%
Hospital Mortality
62%
Bleeding
55%
Acute Pancreatitis
50%
Polymyxin B
50%
Hemoperfusion
50%
Total Hip Arthroplasty
50%
Cost-Effectiveness Analysis
50%
Vonoprazan
46%
Health Care Cost
45%
Patient with Ulcerative Colitis
44%
Proton-Pump Inhibitor
43%
Endoscopic Submucosal Dissection
41%
Logistic Regression Analysis
38%
Disease Activity
37%
Septic Shock
35%
Subgroup Analysis
34%
Primary Sclerosing Cholangitis
33%
Congestive Heart Failure
33%
Neuromyelitis Optica
33%
Analgesia
33%
Inflammatory Arthritis
33%
Rheumatoid Arthritis
33%
Intensive Care Unit
33%
Disease Course
32%
Inflammatory Bowel Disease
28%
Pulmonary Embolism
25%
Sepsis
25%
Sequela
25%
Mortality Rate
24%
Cohort Analysis
22%
Infliximab
22%
Patient with Inflammatory Bowel Disease
20%
SOFA Score
20%
Multivariate Analysis
20%
Disseminated Intravascular Coagulation
20%
Noradrenalin
19%
Malignant Neoplasm
18%
Colorectal Carcinoma
18%
Biological Product
18%
Comorbidity
17%
Neck Infection
16%
Pediatrics
16%
Epidural Analgesia
16%
Patient with Crohn's Disease
16%
Pharmacology, Toxicology and Pharmaceutical Science
Polymyxin B
66%
Hemoperfusion
66%
Hip Fracture
66%
Hospital Mortality
55%
Observational Study
50%
Sepsis
44%
Septic Shock
36%
Ulcerative Colitis
33%
Myelooptic Neuropathy
33%
Vonoprazan
33%
Congestive Heart Failure
33%
Diseases
30%
Proton Pump Inhibitor
27%
Kidney Disease
25%
Loop Diuretic Agent
25%
Tolvaptan
25%
Heart Infarction
21%
Lung Embolism
21%
Noradrenalin
19%
Cohort Study
16%
Disease Activity
16%
Cholangitis
16%
Disseminated Intravascular Clotting
16%
Primary Sclerosing Cholangitis
16%
Organ Dysfunction Score
16%
Malignant Neoplasm
16%
Congestive Cardiomyopathy
16%
Syndrome
16%
Thrombomodulin
16%
Upper Gastrointestinal Bleeding
16%
Ustekinumab
16%
Atrial Fibrillation
16%
Electrolyte Disturbance
16%
Multiple Sclerosis
16%
Antiarrhythmic Agent
16%
Crohn's Disease
16%
Necrosis
16%
Meningitis
16%
Personality Disorder
16%
Direct Oral Anticoagulant
16%
Rheumatoid Arthritis
16%
Inflammatory Arthritis
16%
Bone Necrosis
16%
Bleeding
15%
Prevalence
14%
Deep Vein Thrombosis
11%
Postnatal Depression
11%
Adjustment Disorder
11%
Bipolar Disorder
11%
Anxiety Disorder
11%
Nursing and Health Professions
Confidence Interval
22%
Intensive Care Unit
20%
Elderly Patient
18%
Odds Ratio
18%
Hospital Readmission
17%
Polymyxin B
16%
Continuous Hemodiafiltration
16%
Hemoperfusion
16%
Hip Fracture
16%
Inflammatory Arthritis
16%
Sepsis
16%
Clinical Practice
16%
Cost Effectiveness Analysis
16%
Intensivist
16%
Rheumatoid Arthritis
16%
Bone Necrosis
16%
Total Hip Prosthesis
16%
Ulcerative Colitis
16%
Congestive Heart Failure
16%
Propensity Score
9%
Patient with Ulcerative Colitis
8%
Quality Adjusted Life Year
7%
Osteoarthritis
7%
Mortality Rate
6%
Incremental Cost-Effectiveness Ratio
6%
Lung Embolism
5%
